Concerns Diverting Active Stocks Direction: EOG Resources (NYSE:EOG), Qorvo, Inc. (NASDAQ:QRVO)

EOG Resources, Inc. (NYSE:EOG) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 1.02% to close at $97.28 with the total traded volume of 1.18 Million shares. EOG Resources, Inc. (EOG) reported, for 2017, the company expects to grow total company crude oil volumes by 18 percent, assuming investment and dividend payments within cash flow at a $50 average oil price. Capital expenditures for 2017 are expected to range from $3.7 to $4.1 billion, including production facilities and gathering, processing and other expenditures, and excluding acquisitions.

The company expects to complete approximately 480 net wells in 2017, compared to 445 net wells in 2016. EOG anticipates flat to lower completed well costs in 2017 versus 2016 levels. The board declared a dividend of $0.1675 per share on EOG’s Common Stock, payable April 28, 2017, to stockholders of record as of April 13, 2017. The indicated annual rate is $0.67 per share. The firm has institutional ownership of 88.50%, while insider ownership included 0.40%. Its price to sales ratio ended at 8.07. EOG attains analyst recommendation of 2.20 with week’s performance of -3.86%.

Qorvo, Inc. (NASDAQ:QRVO) [Trend Analysis] climbed reacts as active mover, shares a gain 0.69% to traded at $66.65 and the percentage gap between open changing to regular change was 0.14%. Qorvo (QRVO) reported that four of Qorvo’s highly integrated, high-performance RF front end solutions have been selected to support breakthrough performance in a recently launched gigabit phone. The firm’s current ratio calculated as 2.70 for the most recent quarter. The firm past twelve months price to sales ratio was 2.83 and price to cash ratio remained 17.14. As far as the returns are concern, the return on equity was recorded as -1.90% and return on investment was -0.20% while its return on asset stayed at -1.50%. The firm has total debt to equity ratio measured as 0.20.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *